Shingo Suda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shingo Suda has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Hidenobu Kamohara
Division of Critical Care and Emergency Medicine, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
1 shared publication - Masatoshi Sugi
Department of Anesthesiology, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
1 shared publication - Mikiko Tomino
Department of Anesthesiology, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
1 shared publication - Takeo Nagura
Division of Critical Care and Emergency Medicine, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
1 shared publication - Toshiaki Ikeda
Division of Critical Care and Emergency Medicine, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
1 shared publication Zen’ichiro Wajima
Department of Anesthesiology, Tokyo Medical University Hachioji Medical Center, Tokyo 193-0998, Japan
1 shared publication
Latest Publications
- Open Access
- 29 June 2019
- Published by MDPI AG in Biomedicines
- Vol. 7 (3) , 47
Comparative Evaluation of Endotoxin Activity Level and Various Biomarkers for Infection and Outcome of ICU-Admitted Patients
Here, we concurrently measured the endotoxin activity (EA) level and levels of multiple biomarkers in patient blood obtained within 24 h after being admitted into the intensive care unit (ICU) and analyzed whether there were links between these markers and their associations with patient conditions and outcomes. The EA levels highly correlated with disease severity and patient survival, and showed a significant positive association with levels of lactate, procalcitonin, presepsin, and interleukin-6. Notably, the EA level was the marker that most highly correlated with the results of blood culture, and the presepsin level was the marker most highly correlated with the survival outcome at 28 days. Thus, the optimal biomarker should be selected based on whether it will be used to discriminate the presence of an infection or to predict survival.
- 29 June 2019
- Published by MDPI AG in Biomedicines
- Vol. 7 (3) , 47
Open AccessComparative Evaluation of Endotoxin Activity Level and Various Biomarkers for Infection and Outcome of ICU-Admitted Patients
Here, we concurrently measured the endotoxin activity (EA) level and levels of multiple biomarkers in patient blood obtained within 24 h after being admitted into the intensive care unit (ICU) and analyzed whether there were links between these markers and their associations with patient conditions and outcomes. The EA levels highly correlated with disease severity and patient survival, and showed a significant positive association with levels of lactate, procalcitonin, presepsin, and interleukin-6. Notably, the EA level was the marker that most highly correlated with the results of blood culture, and the presepsin level was the marker most highly correlated with the survival outcome at 28 days. Thus, the optimal biomarker should be selected based on whether it will be used to discriminate the presence of an infection or to predict survival.